We are committed to rigorous science and innovative drug development, and we are excited to share our ongoing progress.
Showing 1 out of 1
Riedl MA, Farkas H, Aygören-Pürsün E, Psarros F, Soteres DF, M.D., Staevska M, Cancian M
New England Journal of Medicine